Valneva is a commercial stage biotech company focused on developing innovative lifesaving vaccines. Valneva is incorporated in Lyon, France, listed on Euronext-Paris and the Vienna stock exchange and has operations in France, Austria, Canada, the US, UK and Nordic countries with over 400 employees.